{"filing":{"accession":"0001193125-26-369287","url":"/filing/0001193125-26-369287","form_type":"4","issuer_cik":"0001809519","issuer_name":"GoodRx Holdings, Inc.","issuer_name_source":null,"issuer_ticker":"GDRX","issuer_url":"/issuer/0001809519","period_of_report":"2026-08-24","filed_date":"2026-08-26","acceptance_dt":"2026-08-26T21:20:35+00:00","acceptance_label":"2026-08-26 21:20 UTC","ingested_at":"2026-08-27T05:24:39.644631+00:00","ingested_label":"2026-08-27 05:24 UTC","schema_version":null,"source":"Layline","parse_status":"parsed","parse_ok":true,"edgar_url":"https://www.sec.gov/Archives/edgar/data/1809519/0001193125-26-369287-index.htm","day_url":"/filings/2026-08-26"},"owners":[{"owner_cik":"0001197853","owner_name":"Francisco Partners Management, LP","url":"/insider/0001197853","anchor":"owner-0001197853","role":"Ten percent owner","officer_title":null,"is_director":false,"is_officer":false,"is_ten_percent":true,"is_other":false,"filing_anchor":"/filing/0001193125-26-369287#owner-0001197853"},{"owner_cik":"0001622902","owner_name":"FRANCISCO PARTNERS IV, L.P.","url":"/insider/0001622902","anchor":"owner-0001622902","role":"Ten percent owner","officer_title":null,"is_director":false,"is_officer":false,"is_ten_percent":true,"is_other":false,"filing_anchor":"/filing/0001193125-26-369287#owner-0001622902"},{"owner_cik":"0001622908","owner_name":"FRANCISCO PARTNERS IV-A, L.P.","url":"/insider/0001622908","anchor":"owner-0001622908","role":"Ten percent owner","officer_title":null,"is_director":false,"is_officer":false,"is_ten_percent":true,"is_other":false,"filing_anchor":"/filing/0001193125-26-369287#owner-0001622908"},{"owner_cik":"0001673966","owner_name":"Francisco Partners GP IV Management Ltd","url":"/insider/0001673966","anchor":"owner-0001673966","role":"Ten percent owner","officer_title":null,"is_director":false,"is_officer":false,"is_ten_percent":true,"is_other":false,"filing_anchor":"/filing/0001193125-26-369287#owner-0001673966"},{"owner_cik":"0001674067","owner_name":"Francisco Partners GP IV, L.P.","url":"/insider/0001674067","anchor":"owner-0001674067","role":"Ten percent owner","officer_title":null,"is_director":false,"is_officer":false,"is_ten_percent":true,"is_other":false,"filing_anchor":"/filing/0001193125-26-369287#owner-0001674067"}],"line_owners":[{"owner_name":"FRANCISCO PARTNERS IV, L.P.; FRANCISCO PARTNERS IV-A, L.P.; Francisco Partners GP IV Management Ltd; Francisco Partners GP IV, L.P.; Francisco Partners Management, LP","role":"Ten percent owner"}],"transactions":[{"id":9301577,"accession":"0001193125-26-369287","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-369287","line_url":"/filing/0001193125-26-369287#line-1","is_derivative":false,"issuer_cik":"0001809519","issuer_name":"GoodRx Holdings, Inc.","issuer_ticker":"GDRX","issuer_name_source":null,"issuer_url":"/issuer/0001809519","owner_cik":null,"owner_name":"FRANCISCO PARTNERS IV, L.P.; FRANCISCO PARTNERS IV-A, L.P.; Francisco Partners GP IV Management Ltd; Francisco Partners GP IV, L.P.; Francisco Partners Management, LP","owner_display_name":"FRANCISCO PARTNERS IV, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":72309.0,"shares_display":"72,309","price_per_share":3.462,"price_display":"3.46","price_state":"stated","total_value":250333.758,"total_display":"250,333.76","total_whole":"250,334","shares_owned_after":716801.0,"shares_owned_after_display":"716,801","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-24","filed_date":"2026-08-26","scope":"global","indirect_nature":"By Francisco Partners IV, L.P.","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9301576,"accession":"0001193125-26-369287","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-369287","line_url":"/filing/0001193125-26-369287#line-2","is_derivative":false,"issuer_cik":"0001809519","issuer_name":"GoodRx Holdings, Inc.","issuer_ticker":"GDRX","issuer_name_source":null,"issuer_url":"/issuer/0001809519","owner_cik":null,"owner_name":"FRANCISCO PARTNERS IV, L.P.; FRANCISCO PARTNERS IV-A, L.P.; Francisco Partners GP IV Management Ltd; Francisco Partners GP IV, L.P.; Francisco Partners Management, LP","owner_display_name":"FRANCISCO PARTNERS IV, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":71285.0,"shares_display":"71,285","price_per_share":3.462,"price_display":"3.46","price_state":"stated","total_value":246788.67,"total_display":"246,788.67","total_whole":"246,789","shares_owned_after":706649.0,"shares_owned_after_display":"706,649","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-24","filed_date":"2026-08-26","scope":"global","indirect_nature":"By Francisco Partners IV-A, L.P.","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9301575,"accession":"0001193125-26-369287","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-26-369287","line_url":"/filing/0001193125-26-369287#line-3","is_derivative":false,"issuer_cik":"0001809519","issuer_name":"GoodRx Holdings, Inc.","issuer_ticker":"GDRX","issuer_name_source":null,"issuer_url":"/issuer/0001809519","owner_cik":null,"owner_name":"FRANCISCO PARTNERS IV, L.P.; FRANCISCO PARTNERS IV-A, L.P.; Francisco Partners GP IV Management Ltd; Francisco Partners GP IV, L.P.; Francisco Partners Management, LP","owner_display_name":"FRANCISCO PARTNERS IV, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":64090.0,"shares_display":"64,090","price_per_share":3.4449,"price_display":"3.44","price_state":"stated","total_value":220783.641,"total_display":"220,783.64","total_whole":"220,784","shares_owned_after":652711.0,"shares_owned_after_display":"652,711","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-25","filed_date":"2026-08-26","scope":"global","indirect_nature":"By Francisco Partners IV, L.P.","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9301574,"accession":"0001193125-26-369287","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-26-369287","line_url":"/filing/0001193125-26-369287#line-4","is_derivative":false,"issuer_cik":"0001809519","issuer_name":"GoodRx Holdings, Inc.","issuer_ticker":"GDRX","issuer_name_source":null,"issuer_url":"/issuer/0001809519","owner_cik":null,"owner_name":"FRANCISCO PARTNERS IV, L.P.; FRANCISCO PARTNERS IV-A, L.P.; Francisco Partners GP IV Management Ltd; Francisco Partners GP IV, L.P.; Francisco Partners Management, LP","owner_display_name":"FRANCISCO PARTNERS IV, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":63183.0,"shares_display":"63,183","price_per_share":3.4449,"price_display":"3.44","price_state":"stated","total_value":217659.1167,"total_display":"217,659.12","total_whole":"217,659","shares_owned_after":643466.0,"shares_owned_after_display":"643,466","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-25","filed_date":"2026-08-26","scope":"global","indirect_nature":"By Francisco Partners IV-A, L.P.","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9301573,"accession":"0001193125-26-369287","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001193125-26-369287","line_url":"/filing/0001193125-26-369287#line-5","is_derivative":false,"issuer_cik":"0001809519","issuer_name":"GoodRx Holdings, Inc.","issuer_ticker":"GDRX","issuer_name_source":null,"issuer_url":"/issuer/0001809519","owner_cik":null,"owner_name":"FRANCISCO PARTNERS IV, L.P.; FRANCISCO PARTNERS IV-A, L.P.; Francisco Partners GP IV Management Ltd; Francisco Partners GP IV, L.P.; Francisco Partners Management, LP","owner_display_name":"FRANCISCO PARTNERS IV, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":213401.0,"shares_display":"213,401","price_per_share":3.5125,"price_display":"3.51","price_state":"stated","total_value":749571.0125,"total_display":"749,571.01","total_whole":"749,571","shares_owned_after":439310.0,"shares_owned_after_display":"439,310","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-26","filed_date":"2026-08-26","scope":"global","indirect_nature":"By Francisco Partners IV, L.P.","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9301572,"accession":"0001193125-26-369287","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001193125-26-369287","line_url":"/filing/0001193125-26-369287#line-6","is_derivative":false,"issuer_cik":"0001809519","issuer_name":"GoodRx Holdings, Inc.","issuer_ticker":"GDRX","issuer_name_source":null,"issuer_url":"/issuer/0001809519","owner_cik":null,"owner_name":"FRANCISCO PARTNERS IV, L.P.; FRANCISCO PARTNERS IV-A, L.P.; Francisco Partners GP IV Management Ltd; Francisco Partners GP IV, L.P.; Francisco Partners Management, LP","owner_display_name":"FRANCISCO PARTNERS IV, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":210378.0,"shares_display":"210,378","price_per_share":3.5125,"price_display":"3.51","price_state":"stated","total_value":738952.725,"total_display":"738,952.72","total_whole":"738,953","shares_owned_after":433088.0,"shares_owned_after_display":"433,088","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-26","filed_date":"2026-08-26","scope":"global","indirect_nature":"By Francisco Partners IV-A, L.P.","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9301571,"accession":"0001193125-26-369287","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001193125-26-369287","line_url":"/filing/0001193125-26-369287#line-7","is_derivative":false,"issuer_cik":"0001809519","issuer_name":"GoodRx Holdings, Inc.","issuer_ticker":"GDRX","issuer_name_source":null,"issuer_url":"/issuer/0001809519","owner_cik":null,"owner_name":"FRANCISCO PARTNERS IV, L.P.; FRANCISCO PARTNERS IV-A, L.P.; Francisco Partners GP IV Management Ltd; Francisco Partners GP IV, L.P.; Francisco Partners Management, LP","owner_display_name":"FRANCISCO PARTNERS IV, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":439310.0,"shares_display":"439,310","price_per_share":3.5,"price_display":"3.50","price_state":"stated","total_value":1537585.0,"total_display":"1,537,585.00","total_whole":"1,537,585","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-26","filed_date":"2026-08-26","scope":"global","indirect_nature":"By Francisco Partners IV, L.P.","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9301570,"accession":"0001193125-26-369287","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001193125-26-369287","line_url":"/filing/0001193125-26-369287#line-8","is_derivative":false,"issuer_cik":"0001809519","issuer_name":"GoodRx Holdings, Inc.","issuer_ticker":"GDRX","issuer_name_source":null,"issuer_url":"/issuer/0001809519","owner_cik":null,"owner_name":"FRANCISCO PARTNERS IV, L.P.; FRANCISCO PARTNERS IV-A, L.P.; Francisco Partners GP IV Management Ltd; Francisco Partners GP IV, L.P.; Francisco Partners Management, LP","owner_display_name":"FRANCISCO PARTNERS IV, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":433088.0,"shares_display":"433,088","price_per_share":3.5,"price_display":"3.50","price_state":"stated","total_value":1515808.0,"total_display":"1,515,808.00","total_whole":"1,515,808","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-26","filed_date":"2026-08-26","scope":"global","indirect_nature":"By Francisco Partners IV-A, L.P.","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null}],"n_transactions":8,"line_constants":{"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true},"provenance":{"source_pass":"Layline","parse_status":"parsed","schema_version":null,"retrieved_at":"2026-08-27T05:24:39.644631+00:00","retrieved_label":"2026-08-27 05:24 UTC","primary_document":"https://www.sec.gov/Archives/edgar/data/1809519/0001193125-26-369287-index.htm","accepted_at":"2026-08-26T21:20:35+00:00","accepted_label":"2026-08-26 21:20 UTC"},"related":[],"related_rule":"Other filings held for the same issuer and the same period of report. This is a heuristic match, not an authoritative amendment link: the store holds no 4/A-to-original relation and the catalog does not invent one.","canonical_url":"https://ebomi.com/filing/0001193125-26-369287","retrieved_at":"2026-08-27T21:06:56+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}